Best Medicare Plans for Heart Disease Medications (2026 Guide)

If you're managing heart disease, your Medicare plan can mean paying $0 or $350/month for the exact same prescription — depending solely on which plan you chose. Statins, blood thinners, beta-blockers, and ACE inhibitors land on very different formulary tiers across plans. Here's how to find one that actually covers what your cardiologist prescribed.

Why Medicare Coverage for Cardiac Medications Varies So Much

Every Medicare Advantage and Part D plan maintains its own formulary — a list of covered drugs organized into cost-sharing tiers. There is no single Medicare drug list. Two plans in the same zip code from the same carrier at the same monthly premium can cover the identical cardiac medication at completely different costs.

For heart disease patients, this variation is especially consequential because cardiac drug regimens often combine multiple medications — a statin for cholesterol, a blood thinner for clot prevention, a beta-blocker for heart rate, an ACE inhibitor for blood pressure. These drugs span the full range from decades-old generics (atorvastatin costs pennies to manufacture) to some of the highest-priced brand-name drugs on the market (Eliquis and Xarelto list above $600/month before insurance).

Plans control costs and coverage by:

• Placing drugs on higher tiers, which increases your out-of-pocket copay or coinsurance
• Requiring prior authorization, so prescriptions need plan approval before coverage kicks in
• Imposing step therapy, where you must try a cheaper drug first (often an older anticoagulant like warfarin) before the plan covers a newer one
• Setting quantity limits that restrict how much of a drug you can fill per fill cycle
• Excluding drugs entirely from the formulary — common with newer brand-name anticoagulants on lower-cost plans

Key Formulary Differences: Statins, Blood Thinners, Beta-Blockers, and ACE Inhibitors

The four main categories of cardiac medications behave very differently across Medicare formularies. Here's what drives the variation and what to watch for when comparing plans.

Statins (Lipitor/atorvastatin, Crestor/rosuvastatin)

Statins are the most commonly prescribed cardiac drugs, and most have been generic for years. Atorvastatin (generic Lipitor) and rosuvastatin (generic Crestor) are available for pennies per pill and placed at Tier 1 or Tier 2 on virtually every Medicare formulary. If you're only on generic statins, your plan choice on drug costs is relatively straightforward — differences will come from other medications and from medical cost-sharing.

However, if your cardiologist prescribes a brand-name statin like Livalo (pitavastatin) or a combination medication, tier placement varies more significantly. Always confirm your specific drug, not just the drug class.

Blood Thinners — Warfarin vs. Novel Anticoagulants (Eliquis, Xarelto, Pradaxa)

This is where the biggest cost variation in cardiac coverage occurs. Warfarin has been generic for decades and costs under $10/month on virtually every plan. The newer anticoagulants — apixaban (Eliquis), rivaroxaban (Xarelto), and dabigatran (Pradaxa) — are still brand-name with no generics available and list prices exceeding $600/month.

The clinical picture is clear: the novel anticoagulants are more convenient (no regular INR monitoring), more predictable, and carry lower bleeding risk in many patients. But many Medicare plans still require step therapy through warfarin before they'll cover Eliquis or Xarelto — meaning you must try and document failure on the older drug first.

If your cardiologist has specifically prescribed a novel anticoagulant, verify whether the plan requires prior authorization or step therapy. Some plans cover Eliquis at Tier 3 with a manageable copay; others place it at Tier 5 with 25–33% coinsurance or exclude it entirely.

Eliquis (apixaban) was among the 10 drugs CMS negotiated directly under the Inflation Reduction Act, with a negotiated price effective January 1, 2026. This lowers the benchmark cost that plan formularies are based on — watch for tier improvements in plans that carry it, though coverage and copays still vary by plan.

Beta-Blockers (metoprolol, carvedilol, atenolol)

Beta-blockers have been generic for decades and are uniformly well-covered across Medicare plans. Metoprolol succinate (Toprol-XL), carvedilol (Coreg), and atenolol are all Tier 1 or Tier 2 on nearly every formulary, with monthly copays of $0–$15. If beta-blockers are your primary cardiac medication, drug coverage differences across plans will be minimal.

ACE Inhibitors and ARBs (lisinopril, ramipril, losartan)

Like beta-blockers, the most commonly prescribed ACE inhibitors and ARBs are old generics. Lisinopril, enalapril, ramipril, losartan, and valsartan are all Tier 1 on most Medicare plans at $0–$10/month copays. Newer combination drugs or brand-name ARBs can be higher-tier — always check your exact prescription.

Plavix (clopidogrel)

Clopidogrel (generic Plavix) is well-covered at Tier 1–2 on most plans, typically $5–$20/month. The brand-name Plavix is significantly more expensive on most formularies. If your prescription specifies brand-name only, check tier placement carefully — generic substitution isn't always clinically appropriate, but most cardiologists will prescribe generic clopidogrel when it's suitable.

Tier placements and copays vary by plan and change annually. Verify your specific plan's formulary before enrolling.

Cardiologist Network Coverage: In-Network vs. Out-of-Network

Drug formulary differences are the most visible cost driver for cardiac patients — but specialist network coverage is equally important, especially for people who've had a recent cardiac event or are under active cardiologist care.

Medicare Advantage plans use network structures. HMO plans require you to stay within the network — seeing an out-of-network cardiologist typically means no coverage at all. PPO plans allow out-of-network care but at significantly higher cost-sharing.

What to verify before choosing a Medicare Advantage plan:

• Is your current cardiologist in the plan's network? (Verify directly with the plan — provider directories are often out of date.)
• Is the hospital where your cardiologist has privileges in-network? (Some cardiologists are listed as in-network but practice primarily at an out-of-network facility.)
• Is the plan an HMO or PPO? If HMO, out-of-network cardiac care in a non-emergency situation is typically not covered.
• Does the plan require a primary care referral to see a specialist, or can you self-refer to your cardiologist?

If you're uncertain whether to stay with Original Medicare (Parts A and B) or choose Medicare Advantage, the cardiologist network question is often the deciding factor. Original Medicare allows you to see any cardiologist who accepts Medicare nationwide — no network restrictions. A Medigap supplemental plan fills the cost-sharing gaps. For patients managing complex cardiac conditions with established specialist relationships, this flexibility can be worth more than the lower premiums some Medicare Advantage plans advertise.

Cardiac Rehab Coverage Under Medicare Part B

Medicare Part B covers cardiac rehabilitation programs for patients who've experienced a qualifying event — heart attack (myocardial infarction), coronary artery bypass surgery, stable angina, heart valve repair or replacement, percutaneous transluminal coronary angioplasty (PTCA) or stenting, or heart or heart-lung transplant.

Under Original Medicare (Part B), cardiac rehab is covered at 80% after the Part B deductible, with the remaining 20% your responsibility (or covered by Medigap). Medicare Advantage plans must cover cardiac rehab at least as generously as Original Medicare, but the cost-sharing structure varies — some plans cover it with a fixed copay per session; others use coinsurance.

When comparing plans, check: (a) the per-session cost-sharing for cardiac rehab, and (b) whether the cardiac rehab facility you'd use is in-network for Medicare Advantage plans you're considering.

Step Therapy and Prior Authorization for Cardiac Drugs

Prior authorization and step therapy requirements are most common for the expensive brand-name cardiac drugs — particularly novel anticoagulants (Eliquis, Xarelto) and any brand-name drug where a generic equivalent is available.

Prior authorization means the plan requires your doctor to submit clinical documentation demonstrating the drug is medically necessary before it will cover the prescription. This can take days to weeks and may require your cardiologist to provide detailed clinical notes.

Step therapy is more aggressive: the plan requires you to try a cheaper alternative first, fail to get adequate results or experience adverse effects, document that failure, and only then will it approve the drug your doctor originally prescribed.

What to do if you hit a step therapy wall:

• Request a step therapy exception immediately. Your cardiologist will need to submit documentation that the required alternative is clinically contraindicated or that you've already tried it and it failed.
• File an expedited appeal if your situation is urgent — plans must respond to expedited coverage determinations within 24 hours for time-sensitive cases.
• Contact your State Health Insurance Assistance Program (SHIP) — free counselors who can help you navigate the appeals process.

5-Step Framework for Comparing Medicare Plans for Heart Disease

Choosing a Medicare plan based on the monthly premium is the most expensive mistake cardiac patients make. Your drug and specialist costs will typically far exceed any premium difference. Here's the right framework:

Step 1: List every cardiac medication you take, with dosage and frequency

Be precise. "Eliquis" and "Eliquis 5mg twice daily" may be on different formulary entries. Some plans cover one dose strength at Tier 3 and another at Tier 5. Know exactly what your cardiologist prescribed.

Step 2: Check each plan's formulary for your specific drugs — including restrictions

Don't assume — look. Every Medicare plan is required to publish its formulary online. For each drug, note: (a) Is it covered? (b) What tier? (c) Are there prior authorization, step therapy, or quantity restrictions? A drug listed as "covered" with step therapy attached is not the same as straightforward Tier 3 coverage.

Step 3: Verify your cardiologist and preferred hospital are in-network

Call the plan directly and confirm — don't rely solely on the online provider directory. Confirm the cardiologist is actively accepting new patients through that plan, and that the hospital where they primarily practice is also in-network. A covered cardiologist at an out-of-network hospital is a gap that can cost thousands.

Step 4: Estimate total annual costs, not just monthly premium

A plan with a $0 premium that places Eliquis at Tier 5 with $145/month cost-sharing costs more than a $45/month premium plan that covers Eliquis at Tier 3 for $65/month — before you account for cardiac rehab sessions, specialist copays, and labs. Build a realistic annual cost estimate across all categories.

Step 5: Check the annual out-of-pocket maximum (MOOP)

The $2,000 Part D cap limits drug cost exposure. But medical cost-sharing — cardiologist visits, echocardiograms, stress tests, cardiac rehab — has its own MOOP. In 2026, CMS caps Medicare Advantage in-network MOOP at $9,350. Some plans set it lower. If you anticipate significant cardiac care utilization, a lower MOOP may save you thousands annually — even at a higher premium.